Cypress Capital, LLC Pfizer Inc Transaction History

Cypress Capital, LLC

$334 Million
Q2 2024

A detailed history of Cypress Capital, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Cypress Capital, LLC holds 1,923 shares of PFE stock, worth $57,036. This represents 0.02% of its overall portfolio holdings.

Number of Shares

1,923

Holding current value

$57,036

% of portfolio

0.02%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 22, 2024	BUY	$25.26 - $29.6 $48,574 - $56,920	1,923 New	1,923 $53,000
Q3 2023 Nov 09, 2023	BUY	$32.09 - $37.51 $57,376 - $67,067	1,788 Added 3.77%	49,208 $1.63 Million
Q2 2023 Aug 07, 2023	BUY	$36.12 - $41.79 $55,444 - $64,147	1,535 Added 3.35%	47,420 $1.74 Million
Q1 2023 Apr 27, 2023	BUY	$39.39 - $51.28 $68,065 - $88,611	1,728 Added 3.91%	45,885 $1.87 Million
Q4 2022 Feb 01, 2023	BUY	$41.75 - $54.5 $18,244 - $23,816	437 Added 1.0%	44,157 $2.26 Million
Q3 2022 Feb 01, 2023	BUY	$43.76 - $53.42 $78,417 - $95,728	1,792 Added 4.27%	43,720 $1.91 Million
Q2 2022 Aug 04, 2022	SELL	$46.53 - $55.17 $65,653 - $77,844	-1,411 Reduced 3.26%	41,928 $2.2 Million
Q1 2022 May 09, 2022	BUY	$45.75 - $56.69 $87,016 - $107,824	1,902 Added 4.59%	43,339 $2.24 Million
Q4 2021 Feb 10, 2022	BUY	$41.32 - $61.25 $6,363 - $9,432	154 Added 0.37%	41,437 $2.45 Million
Q3 2021 Feb 10, 2022	BUY	$39.25 - $50.42 $171,247 - $219,982	4,363 Added 11.82%	41,283 $1.78 Million
Q2 2021 Aug 16, 2021	BUY	$35.91 - $40.68 $208,601 - $236,310	5,809 Added 18.67%	36,920 $1.45 Million
Q1 2021 May 17, 2021	BUY	$33.49 - $37.77 $119,793 - $135,103	3,577 Added 12.99%	31,111 $1.13 Million
Q4 2020 Feb 16, 2021	SELL	$33.47 - $42.56 $1,137 - $1,447	-34 Reduced 0.12%	27,534 $1.01 Million
Q3 2020 Nov 12, 2020	SELL	$31.75 - $37.25 $93,440 - $109,626	-2,943 Reduced 9.65%	27,568 $1.02 Million
Q2 2020 Aug 20, 2020	BUY	$30.12 - $36.54 $323,368 - $392,293	10,736 Added 54.29%	30,511 $998,000
Q4 2019 Feb 10, 2020	BUY	$32.92 - $37.36 $34,302 - $38,929	1,042 Added 5.56%	19,775 $775,000
Q3 2019 Nov 21, 2019	BUY	$32.49 - $42.13 $44,576 - $57,802	1,372 Added 7.9%	18,733 $673,000
Q2 2019 Jul 11, 2019	BUY	$36.98 - $41.52 $26,736 - $30,018	723 Added 4.35%	17,361 $752,000
Q1 2019 May 01, 2019	BUY	$37.5 - $41.2 $43,725 - $48,039	1,166 Added 7.54%	16,638 $707,000
Q4 2018 Feb 14, 2019	BUY	$38.47 - $43.86 $595,207 - $678,601	15,472 New	15,472 $675,000

Others Institutions Holding PFE

# of Institutions

3,218

Shares Held

3.71B

Call Options Held

73.2M

Put Options Held

108M

Vanguard Group Inc Valley Forge, PA

511M
Shares

$15.2 Billion
0.28% of portfolio
Black Rock Inc. New York, NY

424M
Shares

$12.6 Billion
0.27% of portfolio
State Street Corp Boston, MA

287M
Shares

$8.51 Billion
0.36% of portfolio
Wellington Management Group LLP Boston, MA

166M
Shares

$4.93 Billion
0.85% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

117M
Shares

$3.48 Billion
0.63% of portfolio

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $166B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cypress Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cypress Capital, LLC with notifications on news.

Account